Display Settings:

Format
Items per page

Send to:

Choose Destination

Results: 1 to 20 of 44

1.

raltegravir

A small molecule with activity against human immunodeficiency virus (HIV). Raltegravir is an integrase inhibitor that blocks the integration of the viral genome into the host DNA, a critical step in the pathogenesis of HIV. [from NCI]

MedGen UID:
404946
Concept ID:
C1871526
Pharmacologic Substance
2.

lopinavir

An antiretroviral drug of the protease inhibitor class used as a fixed-dose combination with RITONAVIR. [from MeSH]

MedGen UID:
145897
Concept ID:
C0674432
Pharmacologic Substance
3.

Ritonavir

An HIV protease inhibitor that works by interfering with the reproductive cycle of HIV. It also inhibits CYTOCHROME P-450 CYP3A. [from MeSH]

MedGen UID:
132886
Concept ID:
C0292818
Pharmacologic Substance
4.

Lopinavir+ritonavir

A combination of the drugs ritonavir and lopinavir. It is used to treat infection with HIV (the virus that causes AIDS). It is also being studied in the treatment of some types of cancer. Lopinavir/ritonavir blocks the ability of HIV to make copies of itself and may help other anticancer drugs work better or may block the growth of cancer cells. Ritonavir blocks the breakdown of lopinavir. Lopinavir/ritonavir is a type of anti-HIV agent and a type of protease inhibitor. [from NCI]

MedGen UID:
215250
Concept ID:
C0939237
Pharmacologic Substance
5.

Reverse Transcriptase Inhibitors

Any substance that inhibits the activity of viral reverse transcriptase, an RNA-dependent DNA polymerase that transcribes viral RNA into DNA during virus replication. [from NCI]

MedGen UID:
79467
Concept ID:
C0282519
Pharmacologic Substance
6.

Elderly person

A person 65 through 79 years of age. For a person older than 79 years, AGED, 80 AND OVER is available. [from MeSH]

MedGen UID:
7927
Concept ID:
C0001792
Finding
7.

Error occurred: cannot get document summary

ID:
775793

8.

Related

MedGen UID:
619805
Concept ID:
C0445223
Finding
9.

Visual Suppression

MedGen UID:
526147
Concept ID:
C0221103
Pathologic Function
10.

Moderate

Indicates the condition may result in noticable adverse adverse consequences but is unlikely to be life-threatening or cause permanent injury.  [from HL7]

MedGen UID:
525853
Concept ID:
C0205081
11.

PROGRESSIVE ENCEPHALOMYELITIS WITH RIGIDITY

MedGen UID:
349287
Concept ID:
C1861457
Disease or Syndrome
12.

Disease Response

The pathologic and/or clinical changes that result from treatment. The changes may include eradication of detectable disease, stabilization of disease, or disease progression. [from NCI]

MedGen UID:
309976
Concept ID:
C1704632
Finding
13.

Thymus Epithelial Neoplasm

MedGen UID:
220416
Concept ID:
C1266101
Neoplastic Process
14.

Adverse event

unintended negative effect of treatments [from CHV]

MedGen UID:
209094
Concept ID:
C0877248
Pathologic Function
15.

Severity

The degree of something undesirable e.g. pain or weather; also, strictness. [from NCI]

MedGen UID:
141003
Concept ID:
C0439793
16.

Severe

A term used to describe cells that look abnormal under a microscope. These cells are more likely to grow and spread quickly than cells in low-grade cancer or in growths that may become cancer. [from NCI]

MedGen UID:
104640
Concept ID:
C0205082
17.

Antimicrobial substance

Any substance or process that kills germs (bacteria, viruses, and other microorganisms that can cause infection and disease). [from NCI]

MedGen UID:
209727
Concept ID:
C1136254
Pharmacologic Substance
18.

A-157378.0

MedGen UID:
205108
Concept ID:
C1110556
Pharmacologic Substance
19.

Norvir

MedGen UID:
195697
Concept ID:
C0678152
Pharmacologic Substance
20.

Anti-Retroviral Agents

Agents used to treat RETROVIRIDAE INFECTIONS. [from MeSH]

MedGen UID:
109361
Concept ID:
C0599685
Pharmacologic Substance

Display Settings:

Format
Items per page

Send to:

Choose Destination

Supplemental Content

Find related data

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...